Anti-α8 integrin immunoliposomes in glomeruli of lupus-susceptible mice: A novel system for delivery of therapeutic agents to the renal glomerulus in systemic lupus erythematosus

Arthritis and Rheumatism

Volumn 58, Issue 12, 2008, Pages 3884-3891

  Scindia, Yogesh ^a   Deshmukh, Umesh ^a   Thimmalapura, Pushpa Rekha ^a   Bagavant, Harini ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA8 INTEGRIN ANTIBODY; ANTIBODY; CD11B ANTIGEN; CELL SURFACE MARKER; FLUORESCENT DYE; IMMUNOLIPOSOME; UNCLASSIFIED DRUG; ALPHA INTEGRIN; INTEGRIN ALPHA8; LIPOSOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FEMALE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; IMMUNOFLUORESCENCE; IN VIVO STUDY; LUPUS ERYTHEMATOSUS NEPHRITIS; MESANGIUM CELL; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; ANTIBODY SPECIFICITY; GLOMERULUS; IMMUNOLOGY; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; PATHOLOGY;

ANIMALS; ANTIBODIES; ANTIBODY SPECIFICITY; FEMALE; FLOW CYTOMETRY; IMMUNOTHERAPY; INJECTIONS, INTRAVENOUS; INTEGRIN ALPHA CHAINS; KIDNEY GLOMERULUS; LIPOSOMES; LUPUS NEPHRITIS; MESANGIAL CELLS; MICE; MICE, INBRED NOD;

EID: 57349198768     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.24026     Document Type: Article

References (34)

1. Xie C, Zhou XJ, Liu X, Mohan C. Enhanced susceptibility to end-organ disease in the lupus-facilitating NZW mouse strain. Arthritis Rheum 2003;48:1080-92.
2. Bagavant H, Deshmukh US, Wang H, Ly T, Fu SM. Role for nephritogenic T cells in lupus glomerulonephritis: progression to renal failure is accompanied by T cell activation and expansion in regional lymph nodes. J Immunol 2006;177:8258-65.
3. Wang H, Bagavant H, Deshmukh U, Fu SM. Glomerular gene expression profiles in different stages of renal disease in a mouse model of systemic lupus erythematosus [abstract]. Arthritis Rheum 2006;54 Suppl 9:S788-9.
4. Qing X, Zavadil J, Crosby MB, Hogarth MP, Hahn BH, Mohan C, et al. Nephritogenic anti-DNA antibodies regulate gene expression in MRL/lpr mouse glomerular mesangial cells. Arthritis Rheum 2006;54:2198-210.
5. lpr mice. J Exp Med 1999;190:1813-24.
6. Shultz PJ, DiCorleto PE, Silver BJ, Abboud HE. Mesangial cells express PDGF mRNAs and proliferate in response to PDGF. Am J Physiol 1988;255(4 Pt 2):F674-84.
7. Lema P, Maier H, Nieto E, Vielhaur V, Luckow B, Mampaso F. Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis. J Am Soc Nephrol 2001;12:1369-82.
8. Herrera GA. Plasticity of mesangial cells: a basis for understanding pathological alterations. Ultrastruct Pathol 2006;30:471-9.
9. Samad A, Sultana Y, Aqil M. Liposomal drug delivery systems: an update review. Curr Drug Deliv 2007;4:297-305.
10. Nellis DF, Giardina SL, Janini GM, Shenoy SR, Marks JD, Tsai R, et al. Preclinical manufacture of anti-HER2 liposome-inserting, scFv-PEG-lipid conjugate. 2. Conjugate micelle identity, purity, stability, and potency analysis. Biotechnol Prog 2005;21:221-32.
11. Kontermann RE. Immunoliposomes for cancer therapy. Curr Opin Mol Ther 2006;8:39-45.
12. Madsen K, Tisher CC. Anatomy of the kidney: elements of normal renal structure and function. In: Brenner BM, editor. Brenner & Rector's the kidney. 7th ed. Philadelphia: Saunders; 2004. p. 3-72.
13. Kramer RH, Cheng YF, Clyman R. Human microvascular endothelial cells use β1 and β3 integrin receptor complexes to attach to laminin. J Cell Bio 1990;111:1233-43.
14. 1-associated α subunit expressed in smooth muscle cells. J Cell Sci 1995;108(Pt 2):537-44.
15. Wagner TE, Frevert CW, Herzog EL, Schnapp LM. Expression of the integrin subunit α8 in murine lung development. J Histochem Cytochem 2003;51:1307-15.
16. Einheber S, Pierce JP, Chow D, Znamensky V, Schnapp LM, Milner TA. Dentate hilar mossy cells and somatostatin-containing neurons are immunoreactive for the α8 integrin subunit: characterization in normal and kainic acid-treated rats. Neuroscience 2001;105:619-38.
17. Huwyler J, Wu D, Pardridge WM. Brain drug delivery of small molecules using immunoliposomes. Proc Natl Acad Sci U S A 1996;93:14164-9.
18. Pardridge WM. Gene targeting in vivo with pegylated immunoliposomes. Methods Enzymol 2003;373:507-28.
19. Waters ST, Fu SM, Gaskin F, Deshmukh US, Sung SSJ, Kannapell CC, et al. NZM2328: a new mouse model of systemic lupus erythematosus with unique genetic susceptibility loci. Clin Immunol 2001;100:372-83.
20. Waters ST, McDuffie M, Bagavant H, Deshmukh US, Gaskin F, Jiang C, et al. Breaking tolerance to double stranded DNA, nucleosome and other nuclear antigens is not required for the pathogenesis of lupus glomerulonephritis. J Exp Med 2004;199:255-64.
21. Sim D, Bagavant H, Ge Y, Gaskin F, Fu SM, Deshmukh US. Combination of multiple genes from lupus and diabetes prone mice leads to a novel mouse model for lupus [abstract]. FASEB J 2008;22:667.12.
22. Bagavant H, Tung KS. Failure of CD25+ T cells from lupus-prone mice to suppress lupus glomerulonephritis and sialoadenitis. J Immunol 2005;175:944-50.
23. Katsuya K, Yaoita E, Yoshida Y, Yamamoto Y, Yamamoto T. An improved method for primary culture of rat podocytes. Kidney Int 2006;69:2101-6.
24. Takemoto M, Asker N, Gerhardt N, Lundkvist A, Johansson BR, Saito Y, et al. A new method for large scale isolation of kidney glomeruli from mice. Am J Pathol 2002;161:799-805.
25. Tuffin G, Waelti E, Huwyler J, Hammer C, Marti HP. Immunoliposome targeting to mesangial cells: a promising strategy for specific drug delivery to the kidney. J Am Soc Nephrol 2005;16:3295-305.
26. Cortes P, Mendez M, Riser BL, Guerin CJ, Guez-Barbero AR, Hassett C, et al. F-actin fiber distribution in glomerular cells: structural and functional implications. Kidney Int 2000;58:2452-61.
27. Isaka Y. Gene therapy targeting kidney diseases: routes and vehicles. Clin Exp Nephrol 2006;10:229-35.
28. Ito K, Chen J, Asano T, Vaughan ED Jr, Poppas DP, Hayakawa M, et al. Liposome-mediated gene therapy in the kidney. Hum Cell 2004;17:17-28.
29. Asgeirsdottir SA, Zwiers PJ, Morselt HW, Moorlag HE, Bakker HI, Heeringa P, et al. Inhibition of proinflammatory genes in anti-GBM glomerulonephritis by targeted dexamethasone-loaded AbEsel liposomes. Am J Physiol Renal Physiol 2008;294:F554-61.
30. Asgeirsdottir SA, Kamps JA, Bakker HI, Zwiers PJ, Heeringa P, van der Weide K, et al. Site-specific inhibition of glomerulonephritis progression by targeted delivery of dexamethasone to glomerular endothelium. Mol Pharmacol 2007;72:121-31.
31. Zoja C, Corna D, Rottoli D, Zanchi C, Abbate M, Remuzzi G. Imatinib ameliorates renal disease and survival in murine lupus autoimmune disease. Kidney Int 2006;70:97-103.
32. Chu TF, Rupnick MA, Kerkela R, Dallabrida SM, Zurakowski D, Nguyen L, et al. Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib. Lancet 2007;370:2011-9.
33. Saxena V, Lienesch DW, Zhou M, Bommireddy R, Azhar M, Doetschman T, et al. Dual roles of immunoregulatory cytokine TGF-β in the pathogenesis of autoimmunity-mediated organ damage. J Immunol 2008;180:1903-12.
34. De Albuquerque DA, Saxena V, Adams DE, Boivin GP, Brunner HI, Witte DP, et al. An ACE inhibitor reduces Th2 cytokines and TGF-β1 and TGF-β2 isoforms in murine lupus nephritis. Kidney Int 2004;65:846-9.